Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia. Al-Samkari H, Mayne TJ, Troutt M, Patle H, et al. Am J Hematol 2025;100:1722-1735.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Al-Samkari H, Mayne TJ, Troutt M, Patle H, et al. Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia. Am J Hematol 2025;100:1722-1735.
PMID: 40600700